SIRT1 Activation Using CRISPR/dCas9 Promotes Regeneration of Human Corneal Endothelial Cells through Inhibiting Senescence

SIRT1 Activation Using CRISPR/dCas9 Promotes Regeneration of Human Corneal Endothelial Cells through Inhibiting Senescence

Human corneal endothelial cells (hCECs) are restricted in proliferative capacity in vivo. Reduction in the number of hCEC leads to persistent corneal edema requiring corneal transplantation. This study demonstrates the functions of SIRT1 in hCECs and its potential for corneal endothelial regeneratio...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Hye Jun Joo, Dae Joong Ma, Jin Sun Hwang, Young Joo Shin
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	MDPI AG 2020-11-01
Sraith:	Antioxidants
Ábhair:	SIRT1 corneal endothelial cells senescence CRISPR/dCas9
Rochtain ar líne:	https://www.mdpi.com/2076-3921/9/11/1085

Míreanna comhchosúla

From DNA-protein interactions to the genetic circuit design using CRISPR-dCas systems
de réir: A. K. Shaytan, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Live imaging and tracking of genome regions in CRISPR/dCas9 knock-in mice
de réir: Jinzhi Duan, et al.
Foilsithe / Cruthaithe: (2018-11-01)

Deciphering Plant Chromatin Regulation via CRISPR/dCas9-Based Epigenome Engineering
de réir: Annick Dubois, et al.
Foilsithe / Cruthaithe: (2021-08-01)

CRISPR/dCas9-Mediated Parkin Inhibition Impairs Mitophagy and Aggravates Apoptosis of Rat Nucleus Pulposus Cells Under Oxidative Stress
de réir: Tao Lan, et al.
Foilsithe / Cruthaithe: (2021-04-01)

CRISPR/dCas9-Based Systems: Mechanisms and Applications in Plant Sciences
de réir: Chou Khai Soong Karlson, et al.
Foilsithe / Cruthaithe: (2021-09-01)

Comparison and optimization of CRISPR/dCas9/gRNA genome-labeling systems for live cell imaging
de réir: Yu Hong, et al.
Foilsithe / Cruthaithe: (2018-03-01)

Targeted eradication of EBV-positive cancer cells by CRISPR/dCas9-mediated EBV reactivation in combination with ganciclovir
de réir: Febri Gunawan Sugiokto, et al.
Foilsithe / Cruthaithe: (2024-07-01)

CRISPR/dCas9-Mediated Gene Silencing in Two Plant Fungal Pathogens
de réir: Yun-mu Zhang, et al.
Foilsithe / Cruthaithe: (2023-02-01)

CRISPR-dCas9-Based Artificial Transcription Factors to Improve Efficacy of Cancer Treatment With Drug Repurposing: Proposal for Future Research
de réir: Alejandro Martinez-Escobar, et al.
Foilsithe / Cruthaithe: (2021-02-01)

CKM and TERT dual promoters drive CRISPR–dCas9 to specifically inhibit the malignant behavior of osteosarcoma cells
de réir: Yawei Hu, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Knockdown of Long Non-coding RNA SNGH3 by CRISPR-dCas9 Inhibits the Progression of Bladder Cancer
de réir: Yu Cao, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Increasing Specificity of Targeted DNA Methylation Editing by Non-Enzymatic CRISPR/dCas9-Based Steric Hindrance
de réir: Daniel M. Sapozhnikov, et al.
Foilsithe / Cruthaithe: (2023-04-01)

The CRISPR-dCas9 interference system suppresses inhA gene expression in Mycobacterium smegmatis
de réir: Nuntita Singpanomchai, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner
de réir: Henriette O’Geen, et al.
Foilsithe / Cruthaithe: (2019-05-01)

The dCas9-based genome editing in Plasmodium yoelii
de réir: Chao Zhang, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Up-Regulating ERIC by CRISPR-dCas9-VPR Inhibits Cell Proliferation and Invasion and Promotes Apoptosis in Human Bladder Cancer
de réir: Jiangeng Yang, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Synthetic CRISPR/dCas9-KRAB system driven by specific PSA promoter suppresses malignant biological behavior of prostate cancer cells through negative feedback inhibition of PSA expression
de réir: Yi Yang, et al.
Foilsithe / Cruthaithe: (2023-11-01)

Engineering Synthetic Signaling Pathways with Programmable dCas9-Based Chimeric Receptors
de réir: Toni A. Baeumler, et al.
Foilsithe / Cruthaithe: (2017-09-01)

Activation of Insulin Gene Expression via Transfection of a CRISPR/dCas9a System Using Magnetic Peptide-Imprinted Nanoparticles
de réir: Mei-Hwa Lee, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Knockdown of LncRNA PANDAR by CRISPR-dCas9 Decreases Proliferation and Increases Apoptosis in Oral Squamous Cell Carcinoma
de réir: Tingting Jia, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology
de réir: Andrew C. Brane, et al.
Foilsithe / Cruthaithe: (2019-02-01)

Quantitative and modularized CRISPR/dCas9-dCpf1 dual function system in Saccharomyces cerevisiae
de réir: Qing Feng, et al.
Foilsithe / Cruthaithe: (2023-10-01)

CRISPR/dCas9-mediated transcriptional improvement of the biosynthetic gene cluster for the epothilone production in Myxococcus xanthus
de réir: Ran Peng, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Precision genome editing in plants: state-of-the-art in CRISPR/Cas9-based genome engineering
de réir: Naoki Wada, et al.
Foilsithe / Cruthaithe: (2020-05-01)

CRISPR/dCas9-KRAB-Mediated Suppression of <i>S100b</i> Restores p53-Mediated Apoptosis in Melanoma Cells
de réir: Samrat Roy Choudhury, et al.
Foilsithe / Cruthaithe: (2023-02-01)

CRISPR/dCas13(Rx) Derived RNA N6‐methyladenosine (m6A) Dynamic Modification in Plant
de réir: Lu Yu, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Bio-SCAN V2: A CRISPR/dCas9-based lateral flow assay for rapid detection of theophylline
de réir: Wenjun Jiang, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Recent Progress and Future Prospect of CRISPR/Cas-Derived Transcription Activation (CRISPRa) System in Plants
de réir: Xiao Ding, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Advances and applications of CRISPR/Cas-mediated interference in Escherichia coli
de réir: Xiaohui Lim, et al.
Foilsithe / Cruthaithe: (2024-03-01)

lncRNA SNHG9 Promotes Cell Proliferation, Migration, and Invasion in Human Hepatocellular Carcinoma Cells by Increasing GSTP1 Methylation, as Revealed by CRISPR-dCas9
de réir: Shanting Ye, et al.
Foilsithe / Cruthaithe: (2021-04-01)

Utilization of CRISPR-Cas genome editing technology in filamentous fungi: function and advancement potentiality
de réir: Qiqing Shen, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Kaposi’s Sarcoma-Associated Herpesvirus Reactivation by Targeting of a dCas9-Based Transcription Activator to the ORF50 Promoter
de réir: Endrit Elbasani, et al.
Foilsithe / Cruthaithe: (2020-08-01)

An Easy and Efficient Strategy for the Enhancement of Epothilone Production Mediated by TALE-TF and CRISPR/dcas9 Systems in Sorangium cellulosum
de réir: Wei Ye, et al.
Foilsithe / Cruthaithe: (2019-11-01)

Epigenetic Targeting of Granulin in Hepatoma Cells by Synthetic CRISPR dCas9 Epi-suppressors
de réir: Hong Wang, et al.
Foilsithe / Cruthaithe: (2018-06-01)

Tuning dCas9's ability to block transcription enables robust, noiseless knockdown of bacterial genes
de réir: Antoine Vigouroux, et al.
Foilsithe / Cruthaithe: (2018-03-01)

Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer
de réir: Charlene Waryah, et al.
Foilsithe / Cruthaithe: (2023-08-01)

CGD: Comprehensive guide designer for CRISPR-Cas systems
de réir: A Vipin Menon, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Start codon disruption with CRISPR/Cas9 prevents murine Fuchs’ endothelial corneal dystrophy
de réir: Hironori Uehara, et al.
Foilsithe / Cruthaithe: (2021-06-01)

Harnessing the evolving CRISPR/Cas9 for precision oncology
de réir: Tianye Li, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Cell Reprogramming With CRISPR/Cas9 Based Transcriptional Regulation Systems
de réir: Ksenia M. Shakirova, et al.
Foilsithe / Cruthaithe: (2020-07-01)